Development of a Novel Flow Cytometry-Based System for White Blood Cell Differential Counts: 10-color LeukoDiff
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Flow cytometry (FCM) is commonly used to identify many cell populations. We developed a white blood cell (WBC) differential counting system for detecting abnormal cells using FCM incorporating 10 colors and 11 antibodies in a single tube, called “10-color LeukoDiff,” and evaluated its performance. Methods: Ninety-one EDTA-anti-coagulated peripheral blood samples from 76 patients were analyzed using 10-color LeukoDiff. We compared 10 color LeukoDiff results with the results of manual differential count (manual diff). WBCs were classified into 17 cell populations: neutrophils, total lymphocytes, T lymphocytes, B lymphocytes, CD5 and CD19 co-expressing lymphocytes, natural killer cells, total monocytes, 16+ monocytes, eosinophils, immature granulocytes, basophils, myeloblasts, B-blasts, T-blasts, myeloid antigen-positive B-blasts, CD19- plasma cells, and 19+ plasma cells. Results: The correlations between the 10-color LeukoDiff and manual diff results were strong (r>0.9) for mature neutrophils, lymphocytes, eosinophils, immature granulocytes, and blasts and moderate for monocytes and basophils (r=0.86 and 0.74, respectively). There was no discrepancy in blast detection between 10-color LeukoDiff and manual diff results. Furthermore, 10-color LeukoDiff could differentiate the lineage of the blasts and separately count chronic lymphocytic leukemic cells and multiple myeloma cells. Conclusions: The 10-color LeukoDiff provided an accurate and comprehensive WBC differential count. The most important ability of 10-color LeukoDiff is to detect blasts accurately. This system is clinically useful, especially for patients with hematologic diseases, such as acute leukemia, chronic lymphocytic leukemia, and multiple myeloma. Application of this system will improve the development of FCM gating strategy designs.
Abstract
Background: Flow cytometry (FCM) is commonly used to identify many cell populations. We developed a white blood cell (WBC) differential counting system for detecting abnormal cells using FCM incorporating 10 colors and 11 antibodies in a single tube, called “10-color LeukoDiff,” and evaluated its performance. Methods: Ninety-one EDTA-anti-coagulated peripheral blood samples from 76 patients were analyzed using 10-color LeukoDiff. We compared 10 color LeukoDiff results with the results of manual differential count (manual diff). WBCs were classified into 17 cell populations: neutrophils, total lymphocytes, T lymphocytes, B lymphocytes, CD5 and CD19 co-expressing lymphocytes, natural killer cells, total monocytes, 16+ monocytes, eosinophils, immature granulocytes, basophils, myeloblasts, B-blasts, T-blasts, myeloid antigen-positive B-blasts, CD19- plasma cells, and 19+ plasma cells. Results: The correlations between the 10-color LeukoDiff and manual diff results were strong (r>0.9) for mature neutrophils, lymphocytes, eosinophils, immature granulocytes, and blasts and moderate for monocytes and basophils (r=0.86 and 0.74, respectively). There was no discrepancy in blast detection between 10-color LeukoDiff and manual diff results. Furthermore, 10-color LeukoDiff could differentiate the lineage of the blasts and separately count chronic lymphocytic leukemic cells and multiple myeloma cells. Conclusions: The 10-color LeukoDiff provided an accurate and comprehensive WBC differential count. The most important ability of 10-color LeukoDiff is to detect blasts accurately. This system is clinically useful, especially for patients with hematologic diseases, such as acute leukemia, chronic lymphocytic leukemia, and multiple myeloma. Application of this system will improve the development of FCM gating strategy designs.
참고문헌 (22)
- Meintker L, "Comparison of automated differential blood cell counts from Abbott Sapphire, Siemens Advia 120, Beckman Coulter DxH 800, and Sysmex. XE-2100 in normal and pathological samples", Am J Clin Pathol, 139, pp.641~650 (2013)
- Eilertsen H, "The usefulness of blast flags on the Sysmex XE-5000 is questionable", Am J Clin Pathol, 139, pp.633~640 (2013)
- Barnes PW, "The International Consensus Group for Hematology review : suggested criteria for action following automated CBC and WBC differential analysis", Lab Hematol, 11, pp.83~90 (2005)
- Novis DA, "Laboratory productivity and the rate of manual peripheral blood smear review : a College of American Pathologists Q-Probes study of 95, 141 complete blood count determinations performed in 263 institutions", Arch Pathol Lab Med, 130, pp.596~601 (2006)
- 김아현, "White blood cell differential counts in severely leukopenic samples: a comparative analysis of different solutions available in modern laboratory hematology", Blood Research, 49(2), pp.120~126 (2014), 대한혈액학회
- Faucher JL, ""6 markers", 5 colors"extended white blood cell differential by flow cytometry, 2007, pp.71, 934~944
- 조용준, "Reliable, Accurate Determination of the Leukocyte Differential of Leukopenic Samples by Using Hematoflow Method", Annals of Laboratory Medicine, 31(3), pp.131~137 (2011), 대한진단검사의학회
- 강지민, "Flow Cytometric White Blood Cell Differential Using CytoDiff is Excellent for Counting Blasts", Annals of Laboratory Medicine, 35(1), pp.28~34 (2015), 대한진단검사의학회
- Cossarizza A, "Cytometry, immunology, and HIV infection : three decades of strong interactions", Cytometry A, 83, pp.680~691 (2013)
- Ratei R, "Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping", Leukemia, 21, pp.1204~1211 (2007)
- Allou K, "The routine leukocyte differential flow cytometry HematoFlow method : a new flagging system for automatic validation", Cytometry B Clin Cytom, 88, pp.375~384 (2015)
- 임미정, "Comparative Quantitative Analysis of Cluster of Differentiation 45 Antigen Expression on Lymphocyte Subsets", Annals of Laboratory Medicine, 31(3), pp.148~153 (2011), 대한진단검사의학회
- Buhlmann L, "Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT", Bone Marrow Transplant, 46, pp.1357~1362 (2011)
- Fernandez-Ruiz M, "Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients", Transpl Infect Dis, 18, pp.552~565 (2016)
- Fujimaki K, "Immune reconstitution assessed during five years after allogeneic bone marrow transplantation", Bone Marrow Transplant, 27, pp.1275~1281 (2001)
- Rueff J, "Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma", Biol Blood Marrow Transplant, 20, pp.896~899 (2014)
- van de Berg PJ, "Circulating lymphocyte subsets in different clinical situations after renal transplantation", Immunology, 136, pp.198~207 (2012)
- Ziegler Heitbrock L, "The CD14+ CD16+ blood monocytes : their role in infection and inflammation", J Leukoc Biol, 81, pp.584~592 (2007)
- Kalina T, "Quality assessment program for EuroFlow protocols : summary results of four-year(2010-2013)quality assurance rounds", Cytometry A, 87, pp.145~156 (2015)
- Matarraz S, "Introduction to the diagnosis and classification of monocytic-lineage leukemias by flow cytometry", Cytometry B Clin Cytom, 92, pp.218~227 (2017)
- van Dongen JJ, "EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes", Leukemia, 26, pp.1908~1975 (2012)
- Zare H, "Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma", Am J Clin Pathol, 137, pp.75~85 (2012)